{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:27:34Z","timestamp":1772796454580,"version":"3.50.1"},"reference-count":26,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.3892\/ol.2014.2319","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T11:06:13Z","timestamp":1404471973000},"page":"1279-1282","source":"Crossref","is-referenced-by-count":13,"title":["Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases"],"prefix":"10.3892","volume":"8","author":[{"given":"CLELIA","family":"MADEDDU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIULIA","family":"GRAMIGNANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PARASKEVAS","family":"KOTSONIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCESCO","family":"PARIBELLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONIO","family":"MACCI\u00d2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,7,4]]},"reference":[{"issue":"Suppl 2","key":"key20180108103938_b1-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.breast.2013.07.032","article-title":"Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer","volume":"22","author":"Jankowitz","year":"2013","journal-title":"Breast"},{"issue":"Suppl 6","key":"key20180108103938_b2-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Senkus","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180108103938_b3-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180108103938_b4-ol-08-03-1279","first-page":"CD004562","article-title":"LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women","author":"Goel","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180108103938_b5-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1200\/JCO.2005.05.551","article-title":"Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188)","volume":"23","author":"Davidson","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108103938_b6-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11912-009-0008-4","article-title":"What is the current status of ovarian suppression\/ablation in women with premenopausal early-stage breast cancer?","volume":"11","author":"Higgins","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"key20180108103938_b7-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ctrv.2010.07.007","article-title":"Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives","volume":"37","author":"Del Mastro","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"key20180108103938_b8-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/sj.bjc.6690280","article-title":"Ovarian cysts in women receiving tamoxifen for breast cancer","volume":"79","author":"Mourits","year":"1999","journal-title":"Br J Cancer"},{"key":"key20180108103938_b9-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","article-title":"Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent","volume":"83","author":"Jordan","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"key20180108103938_b10-ol-08-03-1279","first-page":"86","article-title":"The effects of tamoxifen therapy on the endometrium","volume":"21","author":"Zarbo","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"key20180108103938_b11-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/00006250-200606000-00057","article-title":"ACOG committee opinion: No. 336: Tamoxifen and uterine cancer","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"key20180108103938_b12-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/gyno.1998.5201","article-title":"Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients","volume":"72","author":"Cohen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"key20180108103938_b13-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9378(96)70386-1","article-title":"Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer","volume":"174","author":"Shushan","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108103938_b14-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0020-7292(95)02590-1","article-title":"Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer","volume":"52","author":"Shushan","year":"1996","journal-title":"Int J Gynecol Obstet"},{"key":"key20180108103938_b15-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1006184028515","article-title":"Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure","volume":"55","author":"Cohen","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108103938_b16-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/oxfordjournals.humrep.a138723","article-title":"Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer","volume":"9","author":"Shulman","year":"1994","journal-title":"Hum Reprod"},{"key":"key20180108103938_b17-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0301-2115(00)00474-7","article-title":"Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with cotreatment of GnRH-agonist","volume":"97","author":"Turan","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20180108103938_b18-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/bcr1830","article-title":"Adjuvant endocrine therapy for premenopausal women with early breast cancer","volume":"9","author":"Bao","year":"2007","journal-title":"Breast Cancer Res"},{"key":"key20180108103938_b19-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"e66616","DOI":"10.1371\/journal.pone.0066616","article-title":"Tamoxifen and ovarian function","volume":"8","author":"Berliere","year":"2013","journal-title":"PLoS One"},{"key":"key20180108103938_b20-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/joe.0.0700421","article-title":"Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women","volume":"70","author":"Groom","year":"1976","journal-title":"J Endocrinol"},{"key":"key20180108103938_b21-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/oxfordjournals.jncimonographs.a003459","article-title":"Adjuvant therapy for very young women with breast cancer: need for tailored treatments","volume":"30","author":"Goldhirsch","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key20180108103938_b22-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"key20180108103938_b23-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(07)60778-8","article-title":"Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials","volume":"369","author":"Cuzick","year":"2007","journal-title":"Lancet"},{"key":"key20180108103938_b24-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","article-title":"Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study","volume":"24","author":"Petrek","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108103938_b25-ol-08-03-1279","first-page":"357","article-title":"Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment","volume":"30","author":"Neri","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"key20180108103938_b26-ol-08-03-1279","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/bjc.2013.324","article-title":"Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial","volume":"109","author":"Yang","year":"2013","journal-title":"Br J Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.2319\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T13:40:47Z","timestamp":1515418847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.2319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,4]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,7,4]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.3892\/ol.2014.2319"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.2319","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,4]]}}}